Wenzhou, China

Chengtan Liu

This inventor holds 1 USPTO granted patent. Top assignee: The Eye Hospital of Wenzhou Medical University. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chengtan Liu. Retrieved from https://idiyas.com/inventor/chengtan-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chengtan Liu: Innovator in Glaucoma Treatment

Introduction

Chengtan Liu is a notable inventor based in Wenzhou, China. He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. His innovative approach aims to improve patient comfort and treatment efficacy.

Latest Patents

Chengtan Liu holds a patent for a glaucoma aqueous humor drainage device and method. This invention features a pressure valve that opens and closes based on changes in intraocular pressure. When the pressure exceeds 12 mmHg, the valve opens, allowing a drainage tube to remove aqueous humor from the eye. This method effectively reduces discomfort and dry eyes for patients, while also preventing complications associated with traditional surgical methods.

Career Highlights

Chengtan Liu is affiliated with The Eye Hospital of Wenzhou Medical University. His work focuses on developing advanced solutions for eye care, particularly for conditions like glaucoma. His dedication to improving patient outcomes is evident in his innovative inventions.

Collaborations

Chengtan Liu collaborates with esteemed colleagues, including Yuanbo Liang and Liang Wen. Their combined expertise contributes to the advancement of ophthalmic technologies and treatments.

Conclusion

Chengtan Liu's contributions to glaucoma treatment through his innovative drainage device highlight his commitment to enhancing patient care. His work continues to pave the way for advancements in ophthalmology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…